rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2008-11-10
|
pubmed:abstractText |
Infliximab treatment results in a decrease in synovial cellularity as early as 48 hours after initiation of therapy in patients with rheumatoid arthritis (RA). This study was undertaken to investigate whether infliximab induces apoptosis within the first 24 hours after infusion.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0004-3591
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3330-9
|
pubmed:meshHeading |
pubmed-meshheading:18975323-Antibodies, Monoclonal,
pubmed-meshheading:18975323-Antirheumatic Agents,
pubmed-meshheading:18975323-Apoptosis,
pubmed-meshheading:18975323-Arthritis, Rheumatoid,
pubmed-meshheading:18975323-Blood Cells,
pubmed-meshheading:18975323-Caspase 3,
pubmed-meshheading:18975323-Complement C4b,
pubmed-meshheading:18975323-Female,
pubmed-meshheading:18975323-Flow Cytometry,
pubmed-meshheading:18975323-Humans,
pubmed-meshheading:18975323-Immunohistochemistry,
pubmed-meshheading:18975323-In Situ Nick-End Labeling,
pubmed-meshheading:18975323-Lymphocyte Count,
pubmed-meshheading:18975323-Lymphocytes,
pubmed-meshheading:18975323-Male,
pubmed-meshheading:18975323-Microscopy, Electron,
pubmed-meshheading:18975323-Middle Aged,
pubmed-meshheading:18975323-Monocytes,
pubmed-meshheading:18975323-Nucleosomes,
pubmed-meshheading:18975323-Synovial Membrane
|
pubmed:year |
2008
|
pubmed:articleTitle |
Analysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients.
|
pubmed:affiliation |
Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|